VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $385,299 | +15.2% | 12,425 | 0.0% | 0.04% | 0.0% |
Q3 2023 | $334,357 | -17.5% | 12,425 | -7.7% | 0.04% | -15.4% |
Q2 2023 | $405,431 | -9.5% | 13,465 | -2.8% | 0.05% | -14.8% |
Q1 2023 | $448,048 | +12.9% | 13,850 | 0.0% | 0.06% | +7.0% |
Q4 2022 | $396,941 | +17.1% | 13,850 | -1.4% | 0.06% | +7.5% |
Q3 2022 | $338,886 | -11.9% | 14,050 | 0.0% | 0.05% | -5.4% |
Q2 2022 | $384,689 | -28.6% | 14,050 | 0.0% | 0.06% | -17.6% |
Q1 2022 | $538,818 | +19.7% | 14,050 | 0.0% | 0.07% | +21.4% |
Q4 2021 | $450,022 | +6.8% | 14,050 | -1.7% | 0.06% | -5.1% |
Q3 2021 | $421,421 | -8.8% | 14,300 | +5.1% | 0.06% | -7.8% |
Q2 2021 | $462,128 | +70.3% | 13,600 | +62.9% | 0.06% | +56.1% |
Q1 2021 | $271,375 | -9.8% | 8,350 | 0.0% | 0.04% | -24.1% |
Q4 2020 | $300,767 | -8.0% | 8,350 | 0.0% | 0.05% | -18.2% |
Q3 2020 | $326,986 | +4.9% | 8,350 | -1.8% | 0.07% | -5.7% |
Q2 2020 | $311,780 | +53.6% | 8,500 | -3.5% | 0.07% | +34.6% |
Q1 2020 | $202,982 | -22.2% | 8,810 | -1.1% | 0.05% | -7.1% |
Q4 2019 | $260,885 | -17.5% | 8,910 | -24.7% | 0.06% | -23.3% |
Q3 2019 | $316,113 | -7.9% | 11,835 | -11.9% | 0.07% | -11.0% |
Q2 2019 | $343,399 | +11.9% | 13,435 | -1.8% | 0.08% | +6.5% |
Q1 2019 | $306,818 | +3.8% | 13,685 | -2.3% | 0.08% | -8.3% |
Q4 2018 | $295,471 | +10.9% | 14,010 | -2.6% | 0.08% | +37.7% |
Q3 2018 | $266,410 | -19.5% | 14,385 | -3.0% | 0.06% | -25.6% |
Q2 2018 | $330,969 | -3.8% | 14,835 | -5.3% | 0.08% | -8.9% |
Q1 2018 | $344,207 | -5.4% | 15,660 | 0.0% | 0.09% | -6.2% |
Q4 2017 | $363,938 | +1.1% | 15,660 | -0.2% | 0.10% | -8.6% |
Q3 2017 | $360,128 | +84.4% | 15,685 | +77.3% | 0.10% | +61.5% |
Q2 2017 | $195,298 | +0.2% | 8,845 | +3.5% | 0.06% | -3.0% |
Q1 2017 | $194,911 | +32.2% | 8,545 | +21.3% | 0.07% | +21.8% |
Q4 2016 | $147,381 | +34.4% | 7,045 | +69.8% | 0.06% | +27.9% |
Q3 2016 | $109,685 | -4.6% | 4,150 | 0.0% | 0.04% | -4.4% |
Q2 2016 | $114,997 | +1.9% | 4,150 | -26.5% | 0.04% | -2.2% |
Q1 2016 | $112,831 | – | 5,650 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |